Sheel Biotech (NSE:SHEEL) Debt-to-EBITDA : (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
21 GF Score
Price ₹60.00
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sheel Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹77 Mil. Sheel Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹12 Mil. Sheel Biotech's annualized EBITDA for the quarter that ended in Mar. 2026 was ₹302 Mil. Sheel Biotech's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was 0.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sheel Biotech's Debt-to-EBITDA or its related term are showing as below:

NSE:SHEEL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.53   Med: 1.62   Max: 3.66
Current: 0.53

During the past 5 years, the highest Debt-to-EBITDA Ratio of Sheel Biotech was 3.66. The lowest was 0.53. And the median was 1.62.

NSE:SHEEL's Debt-to-EBITDA is ranked better than
77.35% of 1572 companies
in the Consumer Packaged Goods industry
Industry Median: 2.115 vs NSE:SHEEL: 0.53

Sheel Biotech  (NSE:SHEEL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Sheel Biotech Debt-to-EBITDA Related Terms

Sheel Biotech Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech Debt-to-EBITDA Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-EBITDA
- - - - -

Sheel Biotech Semi-Annual Data
Sep24 Mar25 Sep25 Mar26
Debt-to-EBITDA - - - -

NSE:SHEEL vs ADM, BG, TSN: Debt-to-EBITDA Comparison

For the Farm Products subindustry, Sheel Biotech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sheel Biotech Debt-to-EBITDA vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sheel Biotech's Debt-to-EBITDA falls into.


NSE:SHEEL
21GF Score
Sheel Biotech Ltd NSE:SHEEL
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sheel Biotech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sheel Biotech's Debt-to-EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(77.353 + 12.438) / 169.962
=0.53

Sheel Biotech's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(77.353 + 12.438) / 301.666
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
21GF Score

Get the complete analysis for NSE:SHEEL

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹60.00
Price